| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
Market |
Healthcare and Medical |
Report Type |
Market Research |
Country |
Global |
Published |
14 January 2013 |
Number of Pages |
195 |
1-3 hours, 24 hour max |
|
Publisher |
Markets&Markets |
File Format |
The global apheresis market is to reach a value of $1,922.4 million by 2017, growing from a previous revenue total in 2012 of $1,140.8 million. The CAGR growth from 2012 to 2017 is estimated at approximately 11%. The global apheresis market is based on a process which uses various technologies and leverage platforms to collect blood, and then to separate it into different components using centrifugation and membrane separation technology.
The apheresis market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market.
Developed markets account for a major share of the apheresis market, whereas emerging countries form the fastest growing markets. North America and Europe collectively contribute to more than 76.2% of the total apheresis market. Asian markets are expected to expand their share in the coming years due to increasing need of blood for transfusion & therapeutic apheresis due to a large population base in these countries.
The key growth strategies adopted by the companies have been studied between 2010 and 2012. Players in this market have adopted various strategies to expand their global footprint and increase market share. New product developments; agreements, partnerships and collaborations; mergers and acquisitions; and expansion are some of the major strategies adopted by players to achieve growth. Agreements, collaborations, joint ventures and partnerships accounted for 42% of the key growth strategies by key players such as Fresenius Medical Care AG (Germany), Cerus Corporation (U.S.), and Haemonetics Corporation (U.S.). For example, in April 2012, Cerus Corporation signed a supply agreement with King Faisal Specialist Hospital, a Saudi Arabia based blood service provider. The agreement allowed the hospital to use the INTERCEPT Blood System to treat its platelet production of around 5,600 units per year.
The research report categorizes the global apheresis market into procedure, application, technology, product type and end-user. All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the apheresis market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.
Global Apheresis Market, by Procedure:
Donor Apheresis
Therapeutic Apheresis
Neurologic Disorders
Blood Disorders (TTP, Leukemia, & Others)
Renal Disease
Metabolic Disorders
Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others)
Global Apheresis Market, by Application:
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukoreduction/leukapheresis
Others (photopheresis, lipidpheresis, and Immunoadsoption)
Global Apheresis Market, by Technology:
Centrifugation
Membrane Separation/Filtration
Global Apheresis Markets, By Product type:
Devices
Disposables
Global Apheresis Markets, By End-user:
Blood banks/Blood collection centers
Hospitals & Hospital attached blood banks
Others
Apheresis Markets, By Geography:
North America
Europe
Asia
RoW (Rest of the World)
Each section of the report also provides market trends with respect to drivers, restraints, and opportunities. The report includes 13 company profiles and its competitive landscape section sketches the strategic developments in the market.
- Therapeutic Apheresis: A US Market Report
- Blood Banking and Blood Products: A Global Strategic Business Report
- Hematology Instruments and Reagents: A Global Strategic Business Report
|
All posts are pre-moderated and must obey the house rules. |
|
Find latest Healthcare and Medical Company Profiles with up to date financial, strategic, operational, SWOT analysis and product information for the leading healthcare and medical companies.
Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.